Oxurion: Exagis adopted by Pierre Fabre

Oxurion NV, a biopharmaceutical company based in Leuven, announced that Pierre Fabre Laboratories are now using Exagis, their clinical data management platform. This choice validates the adaptability and effectiveness of Oxurion's solution, developed by its subsidiary Axiodis CRO.

Exagis was designed to structure and collect clinical data efficiently and in compliance with regulations. It is described as modular, meeting the diverse needs of small biotech companies and large pharmaceutical firms. This adoption by a recognized player strengthens Exagis's credibility, which Pascal Ghoson, CEO of Oxurion, considers a strategic asset for the company.

Aline Stennevin, from Pierre Fabre, emphasizes that the platform combines ease of use with operational rigor.